Who owns SENTI BIOSCIENCES INC?
- Ticker: SNTI
- CUSIP Number: 81726a209
Tip: Access positions for across all investors
Analyze quarterly positions in Senti Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Senti Biosciences stock
Who bought or sold SENTI BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 3.8M | $4.2M | 0% | Jun 2026 |
|
| State Street Corporation | 10k | $8.1k | 0% | Mar 2026 |
|
| Morgan Stanley | 160.00 | $130.000000 | 0% | Mar 2026 |
|
Who sold out of Senti Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Mar 2026 | 888k | $721k |
| Vanguard Capital Management | Mar 2026 | 538k | $437k |
| Geode Capital Management | Mar 2026 | 207k | $168k |
| Vanguard Fiduciary Trust | Mar 2026 | 91k | $74k |
| Menlo Ventures Management | Mar 2026 | 36k | $29k |
| BlackRock | Mar 2026 | 25k | $20k |
| XTX Topco | Mar 2026 | 17k | $14k |
| Northern Trust | Mar 2026 | 17k | $14k |
| Hrt Financial | Mar 2026 | 15k | $12k |
| Goss Wealth Management | Mar 2026 | 12k | $9.7k |
| UBS Group | Mar 2026 | 8.6k | $7.0k |
| SBI Securities | Mar 2026 | 334.00 | $271.007600 |